Publications

Check our publications

Publications

Since 2007 GENVIP has published more than 430 publications

Showing 0 de
0 publications
highlight
Reset everything

Año

Reset

Journal

Reset
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Filters appied:
Tag
close icon
Sort by
Evaluation of 13-valent pneumococcal conjugate vaccine and concomitant meningococcal group C conjugate vaccine in healthyinfants and toddlers in Spain
Javier Diez-Domingo, Alejandra Gurtman, Enrique Bernaola, Francisco Gimenez-Sanchez, Federico Martinon-Torres, Valentin Pineda-Solas, Alfonso Delgado, Pilar Infante-Marquez, John Z. Liang, Peter C. Giardina, William C. Gruber, Emilio A. Emini, Daniel A. Scott
Journal:
Vaccine
Publicación independiente
Impact factor
3.143
Q2
Year:
2013
Doi:
https://doi.org/10.1016/j.vaccine.2013.06.049
THE NEVER ENDING STORY OF CORTICOSTEROIDS IN ACUTE BRONCHIOLITIS
Martinón-Torres F, Montero-Martín M.
Journal:
Pediatrics
Publicación independiente
Impact factor
5.359
Q1
Year:
2013
Doi:
Noninvasive ventilation with helium-oxygen in children
Federico Martinón Torres
Journal:
J. Crit Care
Publicación independiente
Impact factor
2.685
Q3
Year:
2012
Doi:
https://doi.org/10.1016/j.jcrc.2011.05.029
Safety of a 2-dose Regimen of a Combined Measles, Mumps, Rubella and Varicella Live Vaccine Manufactured With Recombinant Human Albumin
Gabriela Rüger, Giovanni Gabutti, Hans Rümke, Lars Rombo, Enrique Bernaola, MD,|| Javier Diez-Domingo, Federico Martinon-Torres, Birthe Høgh, Antreas Konstantopoulos, Anne Fiquet, Stéphane Thomas, Cécile Eymin and Martine Baudin,
Journal:
Pediatr Infect Dis J.
Publicación independiente
Impact factor
2.126
Q1
Year:
2012
Doi:
https://doi.org/10.1097/INF.0b013e318267fd8b
A reverse evidence of rotavirus vaccines impact.
Federico Martinón-Torres, Angela Aramburo, Nazareth Martinón-Torres, Miriam Cebey, María Teresa Seoane-Pillado, Lorenzo Redondo-Collazo and Jose Maria Martinón-Sánchez
Journal:
Human Vaccines & Immunother
Publicación independiente
Impact factor
2.619
Q2
Year:
2013
Doi:
https://doi.org/10.4161/hv.24182
Management of acute bronchiolitis in emergency wards in Spain: variability and appropriateness analysis (Abreviado project)
Ochoa Sangrador C, González de Dios J; Research Group of the aBREVIADo Project (Bronchiolitis--Study of Variability, Adequacy, and Adherence) (Martinón –Torres F).
Journal:
European J of Ped.
Publicación independiente
Impact factor
2.126
Q2
Year:
2012
Doi:
Pleural antigen assay in the diagnosis of pediatric pneumococcal empyema
Federico Martinón-Torres, Silvia Dosil-Gallardo, María Luisa Perez del Molino-Bernal, Fernanda Pardo Sánchez , David Tarrago, Fernando Alvez, Sonia Pertega Diaz, Nazareth Martinón-Torres, Jose Maria Martinon Sanchez
Journal:
J. Crit Care
Publicación independiente
Impact factor
2.685
Q3
Year:
2012
Doi:
https://doi.org/10.1016/j.jcrc.2011.05.004
Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2 trial.
Richmond PC, Marshall HS, Nissen MD, Jiang Q, Jansen KU, Garcés-Sánchez M, Martinón-Torres F, Beeslaar J, Szenborn L, Wysocki J, Eiden J, Harris SL, Jones TR, Perez JL; 2001 Study Investigators.
Journal:
Lancet Infect Dis
Publicación independiente
Impact factor
24.446
Q1
Year:
2012
Doi:
https://doi.org/10.1016/S1473-3099(12)70087-7
Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: a randomized controlled trial.
Gossger N, Snape MD, Yu LM, Finn A, Bona G, Esposito S, Principi N, Diez-Domingo J, Sokal E, Becker B, Kieninger D, Prymula R, Dull P, Ypma E, Toneatto D, Kimura A, Pollard AJ; European MenB Vaccine Study Group.
Journal:
JAMA
Publicación independiente
Impact factor
45.540
Q1
Year:
2012
Doi:
Acute gastroenteritis hospitalizations among children aged < 5 years before and after introduction of rotavirus vaccines: a hospital-based surveillance study in Galicia, Spain.
Federico Martinón-Torres, Nazareth Martinón-Torres, Marta Bouzón Alejandro, Lorenzo Redondo Collazo, Sonia Pértega-Díaz, María Teresa Seoane-Pillado, Jorge Aboal Viñas & María San-Martín
Journal:
Human Vaccines & Immunother
Publicación independiente
Impact factor
2.619
Q2
Year:
2012
Doi:
https://doi.org/10.4161/hv.20178
13-valent pneumococcal conjugate vaccine given with meningococcal C-tetanus toxoid conjugate and other routine pediatric vaccinations: immunogenicity and safety.
Federico Martinón-Torres, Francisco Gimenez-Sanchez, Alejandra Gurtman, Enrique Bernaola, Javier Diez-Domingo, Alfonso Carmona, Mohinder Sidhu, Denise A. Sarkozy, William C. Gruber, Emilio A. Emini, and Daniel A. Scott, on behalf of the 3007 Study Group
Journal:
Pediatr Inf Dis J
Publicación independiente
Impact factor
2.126
Q2
Year:
2012
Doi:
https://doi.org/10.1097/INF.0b013e31824b972b
Mechanical ventilation in pediatric intensive care units during the season for acute lower respiratory infection: a multicenter study.
Farias JA, Fernández A, Monteverde E, Flores JC, Baltodano A, Menchaca A, Poterala R, Pánico F, Johnson M, von Dessauer B, Donoso A, Zavala I, Zavala C, Troster E, Peña Y, Flamenco C, Almeida H, Nilda V, Esteban A; Latin-American Group for Mechanical Ventilation in Children (Martinón-Torres F).
Journal:
Pediatr Crit Care Med
Publicación independiente
Impact factor
2.854
Q1
Year:
2012
Doi:
Immunogenicity of a combination vaccine containing diphtheria toxoid, tetanus toxoid, three-component acellular pertussis, hepatitis B, inactivated polio virus, and Haemophilus influenzae type b when given concomitantly with 13-valent pneumococcal conjugate vaccine
Gimenez-Sanchez F, Kieninger DM, Kueper K, Martinon-Torres F, Bernaola E, Diez-Domingo J, Steul K, Juergens C, Gurtman A, Giardina P, Liang JZ, Gruber WC, Emini EA, Scott DA; 501 and 006 study groups.
Journal:
Vaccine
Publicación independiente
Impact factor
3.143
Q2
Year:
2011
Doi:
https://doi.org/10.1016/j.vaccine.2011.06.026
Vacuna universal frente a meningococo B
Carmen Rodríguez-Tenreiro, Federico Martinón-Torres
Journal:
An Pediatr Contin
Publicación independiente
Impact factor
1.313
Q4
Year:
2011
Doi:
https://doi.org/10.1016/S1696-2818(11)70008-7
Prospective evaluation of indirect costs due to acute rotavirus gastroenteritis in Spain: the ROTACOST study
Bouzón-Alejandro M, Redondo-Collazo L, Sánchez-Lastres JM, Martinón-Torres N, Martinón-Sánchez JM, Martinón-Torres F; ROTACOST research team
Journal:
BMC Pediatrics
Publicación independiente
Impact factor
1.909
Q2
Year:
2011
Doi:
https://doi.org/10.1186/1471-2431-11-81
Effectiveness of rotavirus vaccination in Spain.
Federico Martinón-Torres, Marta Bouzón Alejandro, Lorenzo Redondo Collazo, Juan Manuel Sánchez Lastres, Sonia Pértega Díaz, Mª Teresa Seoane Pillado & José María Martinón Sánchez
Journal:
Human Vaccines
Publicación independiente
Impact factor
2.619
Q2
Year:
2011
Doi:
https://doi.org/10.4161/hv.7.7.15576
Considerations on the clinical application of the human papillomavirus vaccine in Spain
Javier Cortés, Federico Martinon-Torres, José Manuel Ramón, Cajal, Gabriel Ferret and Angel Gil
Journal:
Human Vaccines
Publicación independiente
Impact factor
2.619
Q2
Year:
2011
Doi:
https://doi.org/10.4161/hv.7.5.14817
Circovirus and impact of temporary withdrawal of rotavirus vaccines in Spain
Marta Bouzón Alejandro, Javier Diez Domingo and Federico Martinón Torres
Journal:
Human Vaccines
Publicación independiente
Impact factor
2.619
Q2
Year:
2011
Doi:
https://doi.org/10.4161/hv.7.7.15683
Candida bloodstream infections in intensive care units: Analysis of the extended prevalence of infection in intensive care unit study
Daniel H. Kett; Elie Azoulay; Pablo M. Echeverria; Jean-Louis Vincent; and for the Extended Prevalence of Infection in the ICU Study (EPIC II) Group of Investigators (F. Martinón-Torres)
Journal:
Crit Care Med.
Publicación independiente
Impact factor
7.414
Q1
Year:
2011
Doi:
Acute lung injury in children: Therapeutic practice and feasibility of international clinical trials
Santschi M, Jouvet P, Leclerc F, Gauvin F, Newth CJ, Carroll CL, Flori H, Tasker RC, Rimensberger PC, Randolph AG; for the PALIVE Investigators, the Pediatric Acute Lung Injury and Sepsis Investigators Network (PALISI); the European Society of Pediatric and Neonatal Intensive Care (ESPNIC) (Martinón-Torres F).
Journal:
Ped Crit Care Med
Publicación independiente
Impact factor
2.854
Q1
Year:
2010
Doi:
The Spanish human papillomavirus vaccine consensus group: A working model
Javier Cortés & Federico Martinón-Torres; Spanish HPV Vaccine Consensus Group.
Journal:
Human Vaccines
Publicación independiente
Impact factor
2.619
Q2
Year:
2010
Doi:
https://doi.org/10.4161/hv.6.8.12011
Multicenter prospective study analysing the role of rotavirus on acute gastroenteritis in Spain
Gimenez-Sanchez F, Delgado-Rubio A, Martinon-Torres F, Bernaola-Iturbe E; Rotascore Research Group.
Journal:
Acta Pediatr
Publicación independiente
Impact factor
2.111
Q1
Year:
2010
Doi:
https://doi.org/10.1111/j.1651-2227.2010.01684.x
Genome-wide association study identifies variants in the CFH region associated with host susceptibility to meningococcal disease
Davila S, Wright VJ, Khor CC, Sim KS, Binder A, Breunis WB, Inwald D, Nadel S, Betts H, Carrol ED, de Groot R, Hermans PW, Hazelzet J, Emonts M, Lim CC, Kuijpers TW, Martinon-Torres F, Salas A, Zenz W, Levin M, Hibberd ML; International Meningococcal Genetics Consortium.
Journal:
Nature Genetics
Publicación independiente
Impact factor
27.603
Q1
Year:
2010
Doi:
https://doi.org/10.1038/ng.640
Estudio de variabilidad en el abordaje de la bronquiolitis aguda en España en relación con la edad de los pacientes
J. González de Dios, C. Ochoa Sangrador, Grupo Investigador del Proyecto aBREVIADo (BRonquiolitis-Estudio de Variabilidad, Idoneidad, ADecuación) (F. Martinón-Torres)
Journal:
An Pediatr
Publicación independiente
Impact factor
1.313
Q4
Year:
2010
Doi:
No results found.
MENINGOCOCCAL GROUP B VACCINE FOR THE PREVENTION OF INVASIVE MENINGOCOCCAL DISEASE CAUSED BY NEISSERIA MENINGITIDIS SEROGROUP B
Rivero Calle, I; Raguindin PF; Gómez Rial, J; Rodríguez-Tenreiro, C; Martinón-Torres, F.
Doi:
Infection and Drug Resistance
Factor de impacto:
Q1
Doi:
A qPCR expression assay of IFI44L gene differentiates viral from bacterial infections in febrile children
Alberto Gómez-Carballa, Miriam Cebey-López, Jacobo Pardo-Seco, Ruth Barral-Arca, Irene Rivero-Calle, Sara Pischedda, María José Currás-Tuala1, José Gómez-Rial, Francisco Barros, Federico Martinón-Torres & Antonio Salas
Doi:
Sci Rep
Factor de impacto:
Doi:
PERSISTENCE OF THE IMMUNE RESPONSE AFTER 4CMENB VACCINATION, AND THE RESPONSE TO AN ADDITIONAL BOOSTER DOSE IN INFANTS, CHILDREN, ADOLESCENTS AND YOUNG ADULTS
Federico Martinón-Torres, Terry Nolan, Daniela Toneatto & Angelika Banzhoff
Doi:
Hum Vaccin Immunother
Factor de impacto:
Q2
Doi:
FALSE VACCINE CONTRAINDICATIONS AMONG HEALTHCARE PROVIDERS IN EUROPE: A SHORT SURVEY AMONG MEMBERS OF THE EUROPEAN SOCIETY OF PEDIATRIC INFECTIOUS DISEASES
Irene Rivero, Peter Francis Raguindin, Robb Buttler and Federico Martinon-Torres
Doi:
Pediatr Infect Dis J.
Factor de impacto:
Q2
Doi:
ASSOCIATION BETWEEN RESPIRATORY SYNCYTIAL VIRUS-ASSOCIATED ACUTE LOWER RESPIRATORY INFECTION IN EARLY LIFE AND RECURRENT WHEEZE AND ASTHMA IN LATER CHILDHOOD
Shi T, Ooi Y, Zaw EM, Utjesanovic N, Campbell H, Cunningham S, Bont L, Nair H, RESCEU Investigators. COLLABORATORS (Nair H, Campbell H, Shi T, Zhang S, Li Y, Openshaw P, Wedzicha J, Falsey A, Miller M, Beutels P, Bont L, Pollard A, Molero E, Martinon-Torres F, Heikkinen T, Meijer A, Fischer TK, Berge MVD, Giaquinto C, Mikolajczyk R, Hackett J, Cai B, Knirsch C, Leach A, Stoszek SK, Gallichan S, Kieffer A, Demont C, Cheret A, Gavart S, Aerssens J, Wyffels V, Cleenewerck M, Fuentes R, Rosen B.)
Doi:
J Infect Dis
Factor de impacto:
Q1
Doi:
USE OF THE WHO ACCESS, WATCH, AND RESERVE CLASSIFICATION TO DEFINE PATTERNS OF HOSPITAL ANTIBIOTIC USE (AWARE):AN ANALYSIS OF PAEDIATRIC SURVEY DATA FROM 56 COUNTRIES
Yingfen Hsia, Brian R Lee, Ann Versporten, Yonghong Yang, Julia Bielicki, Charlotte Jackson, Jason Newland, Herman Goossens, Nicola Magrini, Mike Sharland on behalf of the GARPEC and Global-PPS networks* (Federico Martinon-Torres)
Doi:
Lancet Glob Health.
Factor de impacto:
Q1
Doi:
CLINICAL PRESENTATION OF INFLUENZA IN CHILDREN 6 TO 35 MONTHS OF AGE: FINDINGS FROM A RANDOMIZED CLINICAL TRIAL OF INACTIVATED QUADRIVALENT INFLUENZA VACCINE
Jasur Danier, Luis Rivera, Carine Claeys, Ghassan Dbaibo, Varsha K. Jain, Pope Kosalaraksa, Wayne Woo, Emad Yanni, Khalequ Zaman, Beatriz Acosta, Arshad Amanullah, Miguel Ariza, Maria L. Arroba Basanta, Ashish Bavdekar, Alfonso Carmona, Luis Cousin, Adolfo Diaz, Javier Diez-Domingo, Ener C. Dinleyici, Saul N. Faust, Jose Garcia-Sicilia, Grace D. Gomez-Go, Maria L. A. Gonzales, Mustafa Hacimustafaoglu, Stephen M. Hughes, Allen Izu, Teresa Jackowska, Shashi Kant, Marilla Lucero, Josep Mares Bermudez, Federico Martinón-Torres, May Montellano, Roman Prymula, Thanyawee Puthanakit,Renata Ruzkova, Iwona Sadowska Krawczenko, Jyoti Soni, Henryk Szymanski, Angels Ulied, Anne Schuind and Bruce L. Innis for the Flu4VEC Study Group
Doi:
Pediatr Infect Dis J.
Factor de impacto:
Q2
Doi:
IMMUNOGENICITY OF THE PNEUMOCOCCAL NON-TYPEABLE HAEMOPHILUS INFLUENZAE PROTEIN D CONJUGATE VACCINE (PHID-CV) ADMINISTERED CONCOMITANTLY WITH THE MENINGOCOCCAL SEROGROUP B (4CMENB) VACCINE IN INFANTS: A POST-HOC ANALYSIS IN A PHASE 3B, RANDOMISED, CONTROLLED TRIAL
Marco Aurelio P. Safadi, Federico Martinon-Torres, Lily Yin Weckx, Edson Duarte Moreira Junior, Eduardo Jorge da Fonseca Lima, Arnold Willemsen, Daniela Toneatto, Md Ahsan Habib, Dorota Borys
Doi:
Vaccine
Factor de impacto:
Q2
Doi:
ANCESTRY PATTERNS INFERRED FROM MASSIVE RNA-SEQ DATA
Barral-Arca, R; Pardo-Seco, J; Bello, X; Martinon-Torres, F; Salas, A
Doi:
RNA
Factor de impacto:
Q2
Doi:
THE RESVINET SCORE FOR BRONCHIOLITIS: A SCALE FOR ALL SEASONS
Justicia-Grande, AJ; Martinon-Torres, F
Doi:
Am J Perinatol
Factor de impacto:
Q3
Doi:
A STRATEGY TARGETING MONOCYTE-MACROPHAGE DIFFERENTIATION TO AVOID PULMONARY COMPLICATIONS IN SARS-COV2 INFECTION
J.Gómez-Rial, F.Martinón-Torres
Clin Immunol
Factor de impacto:
Q2
Doi:
MAPPING GENOME VARIATION OF SARS-COV-2 WORLDWIDE HIGHLIGHTS THE IMPACT OF COVID-19 SUPER-SPREADERS
Alberto Gómez-Carballa, Xabier Bello, Jacobo Pardo-Seco, Federico Martinón-Torres, Antonio Salas
bioRxiv
Factor de impacto:
Q1
Doi:
CLINICAL CHARACTERISTICS OF 58 CHILDREN WITH A PEDIATRIC INFLAMMATORY MULTISYSTEM SYNDROME TEMPORALLY ASSOCIATED WITH SARS-COV-2
Elizabeth Whittaker; Alasdair Bamford; Julia Kenny; Myrsini Kaforou; Christine E. Jones; Priyen Shah; Padmanabhan Ramnarayan; Alain Fraisse; Owen Miller; Patrick Davies; Filip Kucera; Joe Brierley; Marilyn McDougall; Michael Carter; Adriana Tremoulet; Chisato Shimizu Jethro Herberg; Jane C. Burns; Hermione Lyall; Michael Levin; for the PIMS-TS Study Group and EUCLIDS and PERFORM Consortia (Federico Martinón-Torres)
JAMA
Factor de impacto:
Q1
Doi:
RNA-SEQ DATA-MINING ALLOWS THE DISCOVERY OF TWO LONG NON-CODING RNA BIOMARKERS OF VIRAL INFECTION IN HUMANS
Ruth Barral-Arca, Alberto Gómez-Carballa, Miriam Cebey-López, María José Currás-Tuala, Sara Pischedda, Sandra Viz-Lasheras, Xabier Bello, Federico Martinón-Torres and Antonio Salas
International J Molecular Sciences
Factor de impacto:
Q1
Doi:
COST OF RESPIRATORY SYNCYTIAL VIRUS-ASSOCIATED ACUTE LOWER RESPIRATORY INFECTION MANAGEMENT IN YOUNG CHILDREN AT THE REGIONAL AND GLOBAL LEVEL: A SYSTEMATIC REVIEW AND META-ANALYSIS.
Zhang S, Akmar LZ, Bailey F, Rath BA, Alchikh M, Schweiger B, Lucero MG, Nillos LT, Kyaw MH, Kieffer A, Tong S, Campbell H, Beutels P, Nair H; RESCEU Investigators
J Infect Dis.
Factor de impacto:
Q1
Doi:
IMMUNOLOGICAL AND INFLAMMATORY BIOMARKERS OF SUSCEPTIBILITY AND SEVERITY IN ADULT RESPIRATORY SYNCYTIAL VIRUS INFECTIONS.
Wiseman DJ, Thwaites RS, Drysdale SB, Janet S, Donaldson GC, Wedzicha JA, Openshaw PJ; RESCEU Investigators
J Infect Dis.
Factor de impacto:
Q1
Doi:
LOW SENSITIVITY OF BINAXNOW RSV IN INFANTS.
Zuurbier RP, Bont LJ, Langedijk AC, Hamer M, Korsten K, Drysdale SB, Snape MD, Robinson H, Pollard AJ, Martinón-Torres F, Rodríguez-Tenreiro Sánchez C, Gómez-Carballa A, Dacosta-Urbieta AI, Heikkinen T, Cunningham S, van Houten MA, Wildenbeest JG; RESCEU Investigators .
J Infect Dis.
Factor de impacto:
Q1
Doi:
PROTECTING THE MOST VULNERABLE AGE GROUP: A REVIEW OF MENACWY-TT IMMUNOGENICITY AND SAFETY IN INFANTS.
Martinón-Torres F, Serra L, Safadi MAP.
Expert Rev Vaccines
Factor de impacto:
Q2
Doi:
PATHWAY TOWARDS AN IDEAL AND SUSTAINABLE FRAMEWORK AGREEMENT FOR THE PUBLIC PROCUREMENT OF VACCINES IN SPAIN: A MULTI-CRITERIA DECISION ANALYSIS.
Zozaya González N, Alcalá Revilla B, Arrazola Martínez P, Chávarri Bravo JR, Cuesta Esteve I, García Rojas A, Martinón-Torres F, Redondo Margüello E, Rivero Cuadrado A, Tamames Gómez S, Villaseca Carmena J, Hidalgo-Vega A
Hum Vaccine Immunother
Factor de impacto:
Q2
Doi:
WHOLE-EXOME SEQUENCING FOR THE IDENTIFICATION OF RARE VARIANTS IN PRIMARY IMMUNODEFICIENCY GENES IN CHILDREN WITH SEPSIS - A PROSPECTIVE POPULATION-BASED COHORT STUDY
Alessandro Borghesi, Johannes Trück, Samira Asgari, Vanessa Sancho-Shimizu, Philipp KA Agyeman, Evangelos Bellos, Eric Giannoni, Martin Stocker, Klara M Posfay-Barbe, Ulrich Heininger, Sara Bernhard-Stirnemann, Anita Niederer-Loher, Christian R Kahlert, Giancardlo Natalucci, Christa Relly, Thomas Riedel, Claudia E Kuehni, Christian W. Thorball, Nimisha Chaturvedi, Federico Martinon-Torres, Taco W Kuijpers, Lachlan Coin, Victoria Wright, Jethro Herberg, Michael Levin, Christoph Aebi, Christoph Berger, Jacques Fellay, Luregn J Schlapbach, for the EUCLIDS consortium and the Swiss Paediatric Sepsis Study
Clin Infect Dis
Factor de impacto:
Q1
Doi:
Links
Department of pediatricsGenCovidNanostringNextSeq
Legal noticePrivacy policy
Genvip 2023® – All rights reserved